F-13 · Numerical Fluency for Biotech
Picture a slide. A drug company is presenting results, and the headline graph shows a tumor-suppressing antibody pulling away from the older treatment. The two lines start together on the left, then the new drug’s line climbs and the old one sags, and by the right edge there’s a fat gap between them. The gap is colored in. Someone has written a percentage next to it. The room nods.
Now look again, this time at the bottom of the graph. The vertical axis doesn’t start at zero — it starts at sixty. The “fat gap” is the distance between a line at 64 and a line at 61. Three points. The colored wedge that looked like a chasm is, in real units, the width of a pencil.
Nobody lied. Every number on that slide is true. The data are real, the percentage is correctly calculated, the lines go exactly where the spreadsheet says. And yet the thing you took away in four seconds — this drug is dramatically better — may not survive a second look. That gap between what the numbers say and what you absorbed is where most people get hurt in biotech, whether they’re investors, patients, or seventeen-year-olds reading their first clinical-trial press release.
Here is the reframing this whole article rests on: the numbers in biotech are mostly honest and mostly misread. Outright fraud is rare and gets caught. What’s common is the ordinary, legal, everywhere gap between a true number and the wrong impression it leaves. So this is a self-defense kit: four of the field’s most reliable number-traps, each with one worked example and one rule of thumb you can carry into any chart, any abstract, any pitch.
